These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19242063)

  • 1. IL-1beta in irrigation fluid and mRNA expression in synovial tissue of the knee joint as therapeutic markers of inflammation in collagen antibody-induced arthritis.
    Chia WT; Yeh LT; Chen YW; Lee HS; Chang DM; Sytwu HK
    Dis Markers; 2009; 26(1):1-7. PubMed ID: 19242063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MMP-9 mRNA as a therapeutic marker in acute and chronic stages of arthritis induced by type II collagen antibody.
    Chia WT; Chen YW; Cheng LY; Lee HS; Chang DM; Sytwu HK
    J Formos Med Assoc; 2008 Mar; 107(3):245-52. PubMed ID: 18400610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Joint production of IL-22 participates in the initial phase of antigen-induced arthritis through IL-1β production.
    Pinto LG; Talbot J; Peres RS; Franca RF; Ferreira SH; Ryffel B; Aves-Filho JC; Figueiredo F; Cunha TM; Cunha FQ
    Arthritis Res Ther; 2015 Sep; 17(1):235. PubMed ID: 26330334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction.
    Lubberts E; Joosten LA; van Den Bersselaar L; Helsen MM; Bakker AC; van Meurs JB; Graham FL; Richards CD; van Den Berg WB
    J Immunol; 1999 Oct; 163(8):4546-56. PubMed ID: 10510398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of cyclin-dependent kinase inhibitor 1-deficient mice to rheumatoid arthritis arising from interleukin-1β-induced inflammation.
    Takashima Y; Hayashi S; Fukuda K; Maeda T; Tsubosaka M; Kamenaga T; Kikuchi K; Fujita M; Kuroda Y; Hashimoto S; Nakano N; Matsumoto T; Kuroda R
    Sci Rep; 2021 Jun; 11(1):12516. PubMed ID: 34131243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced expression and proteolytic susceptibility of lubricin/superficial zone protein may explain early elevation in the coefficient of friction in the joints of rats with antigen-induced arthritis.
    Elsaid KA; Jay GD; Chichester CO
    Arthritis Rheum; 2007 Jan; 56(1):108-16. PubMed ID: 17195213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of two new arthritis severity loci that regulate levels of autoantibodies, interleukin-1β, and joint damage in pristane- and collagen-induced arthritis.
    Brenner M; Laragione T; Shah A; Mello A; Remmers EF; Wilder RL; Gulko PS
    Arthritis Rheum; 2012 May; 64(5):1369-78. PubMed ID: 22076633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage migration inhibitory factor up-regulates the expression of interleukin-8 messenger RNA in synovial fibroblasts of rheumatoid arthritis patients: common transcriptional regulatory mechanism between interleukin-8 and interleukin-1beta.
    Onodera S; Nishihira J; Koyama Y; Majima T; Aoki Y; Ichiyama H; Ishibashi T; Minami A
    Arthritis Rheum; 2004 May; 50(5):1437-47. PubMed ID: 15146413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 17 (IL-17) increases the expression of Toll-like receptor-2, 4, and 9 by increasing IL-1beta and IL-6 production in autoimmune arthritis.
    Lee JH; Cho ML; Kim JI; Moon YM; Oh HJ; Kim GT; Ryu S; Baek SH; Lee SH; Kim HY; Kim SI
    J Rheumatol; 2009 Apr; 36(4):684-92. PubMed ID: 19228664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of high-mobility group box protein 1 in collagen antibody-induced arthritis is dependent on vascular endothelial growth factor.
    Biscetti F; Flex A; Pecorini G; Angelini F; Arena V; Stigliano E; Gremese E; Tolusso B; Ferraccioli G
    Clin Exp Immunol; 2016 Apr; 184(1):62-72. PubMed ID: 26671547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of arthritis severity in protease-activated receptor-deficient mice.
    Yang YH; Hall P; Little CB; Fosang AJ; Milenkovski G; Santos L; Xue J; Tipping P; Morand EF
    Arthritis Rheum; 2005 Apr; 52(4):1325-32. PubMed ID: 15818676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
    Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
    Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis.
    Lubberts E; Joosten LA; Oppers B; van den Bersselaar L; Coenen-de Roo CJ; Kolls JK; Schwarzenberger P; van de Loo FA; van den Berg WB
    J Immunol; 2001 Jul; 167(2):1004-13. PubMed ID: 11441109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adiponectin mitigates the severity of arthritis in mice with collagen-induced arthritis.
    Lee SW; Kim JH; Park MC; Park YB; Lee SK
    Scand J Rheumatol; 2008; 37(4):260-8. PubMed ID: 18612926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ASC plays a role in the priming phase of the immune response to type II collagen in collagen-induced arthritis.
    Yamazaki H; Takeoka M; Kitazawa M; Ehara T; Itano N; Kato H; Taniguchi S
    Rheumatol Int; 2012 Jun; 32(6):1625-32. PubMed ID: 21331573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Citrullination of synovial proteins in murine models of rheumatoid arthritis.
    Vossenaar ER; Nijenhuis S; Helsen MM; van der Heijden A; Senshu T; van den Berg WB; van Venrooij WJ; Joosten LA
    Arthritis Rheum; 2003 Sep; 48(9):2489-500. PubMed ID: 13130468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin (IL)-23 p19 expression induced by IL-1beta in human fibroblast-like synoviocytes with rheumatoid arthritis via active nuclear factor-kappaB and AP-1 dependent pathway.
    Liu FL; Chen CH; Chu SJ; Chen JH; Lai JH; Sytwu HK; Chang DM
    Rheumatology (Oxford); 2007 Aug; 46(8):1266-73. PubMed ID: 17569750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1.
    Koenders MI; Lubberts E; Oppers-Walgreen B; van den Bersselaar L; Helsen MM; Di Padova FE; Boots AM; Gram H; Joosten LA; van den Berg WB
    Am J Pathol; 2005 Jul; 167(1):141-9. PubMed ID: 15972960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased production of intracellular interleukin-1 receptor antagonist type I in the synovium of mice with collagen-induced arthritis: a possible role in the resolution of arthritis.
    Gabay C; Marinova-Mutafchieva L; Williams RO; Gigley JP; Butler DM; Feldmann M; Arend WP
    Arthritis Rheum; 2001 Feb; 44(2):451-62. PubMed ID: 11229477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis.
    Palmer G; Talabot-Ayer D; Lamacchia C; Toy D; Seemayer CA; Viatte S; Finckh A; Smith DE; Gabay C
    Arthritis Rheum; 2009 Mar; 60(3):738-49. PubMed ID: 19248109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.